Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG Revaccination and Childhood Mortality in Guinea-Bissau
NCT00126217Phase 4Terminated
- Sponsor
- Bandim Health Project
- Start
- Jul 2002
- Primary completion
- May 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bcg vaccine in malaria and Tuberculosis (TB) (2 arms), sponsored by Bandim Health Project. Primary endpoints: Mortality till 5 years of age, Hospitalisations till 5 years of age and 1 more. Started Jul 2002; status: terminated.
02
Drugs
bcg vaccine
03
Conditions
malariaTuberculosis (TB)
Beyond the preview
Go deeper on NCT00126217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00126217.